Table I.
No. of patients | 25 |
Age, range (median), ys | 53–86 (65) |
Gender, M/F, no of patients | 19/6 |
Disease duration, range (median), mos | 0.53–115 (17) |
WHO stage, no. of patients | |
RA | 4 |
RCMD | 15 |
RARS | 2 |
RCMD-RS | 3 |
RAEB-1 | 1 |
IPSS risk group, no. of patients | |
Low | 11 |
Intermediate-1 | 14 |
Cytogenetic Risk Group, no. of patients | |
Good | 20 |
Intermediate | 4 |
Poor | 1 |